Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1999 Sep;8(9):1904–1907. doi: 10.1110/ps.8.9.1904

Monomer-trimer equilibrium of the ectodomain of SIV gp41: insight into the mechanism of peptide inhibition of HIV infection.

M Caffrey 1, J Kaufman 1, S Stahl 1, P Wingfield 1, A M Gronenborn 1, G M Clore 1
PMCID: PMC2144406  PMID: 10493592

Abstract

The monomer-trimer equilibrium of the ectodomain of SIV gp41 (residues 27-149, e-gp41) has been characterized by analytical ultracentrifugation, circular dichroism (CD), and NMR spectroscopy. Based on analytical ultracentrifugation experiments performed at different rotor speeds and protein concentrations, the equilibrium association constant for the SIV e-gp41 trimer is 3.1 x 10(11) M(-2). The presence of intermolecular nuclear Overhauser effects in a mixture of 12C and 13C-labeled e-gp41 prepared under nondenaturing conditions unambiguously demonstrates that there is a dynamic equilibrium between the monomer and trimer. The CD spectra taken as a function of SIV e-gp41 concentration suggest that the helical content of the monomeric state does not change significantly relative to that of the trimeric state. The relevance of the monomer-trimer equilibrium is discussed with respect to gp41 function and the inhibitory properties of gp41 peptides.

Full Text

The Full Text of this article is available as a PDF (409.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blacklow S. C., Lu M., Kim P. S. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry. 1995 Nov 21;34(46):14955–14962. doi: 10.1021/bi00046a001. [DOI] [PubMed] [Google Scholar]
  2. Caffrey M., Cai M., Kaufman J., Stahl S. J., Wingfield P. T., Covell D. G., Gronenborn A. M., Clore G. M. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 1998 Aug 17;17(16):4572–4584. doi: 10.1093/emboj/17.16.4572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Caffrey M., Cai M., Kaufman J., Stahl S. J., Wingfield P. T., Gronenborn A. M., Clore G. M. Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy. J Mol Biol. 1997 Sep 5;271(5):819–826. doi: 10.1006/jmbi.1997.1217. [DOI] [PubMed] [Google Scholar]
  4. Caffrey M., Kaufman J., Stahl S. J., Wingfield P. T., Gronenborn A. M., Clore G. M. 3D NMR experiments for measuring 15N relaxation data of large proteins: application to the 44 kDa ectodomain of SIV gp41. J Magn Reson. 1998 Dec;135(2):368–372. doi: 10.1006/jmre.1998.1583. [DOI] [PubMed] [Google Scholar]
  5. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 1997 Apr 18;89(2):263–273. doi: 10.1016/s0092-8674(00)80205-6. [DOI] [PubMed] [Google Scholar]
  6. Clore G. M., Gronenborn A. M. Determining the structures of large proteins and protein complexes by NMR. Trends Biotechnol. 1998 Jan;16(1):22–34. doi: 10.1016/S0167-7799(97)01135-9. [DOI] [PubMed] [Google Scholar]
  7. Frankel A. D., Young J. A. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem. 1998;67:1–25. doi: 10.1146/annurev.biochem.67.1.1. [DOI] [PubMed] [Google Scholar]
  8. Kilby J. M., Hopkins S., Venetta T. M., DiMassimo B., Cloud G. A., Lee J. Y., Alldredge L., Hunter E., Lambert D., Bolognesi D. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med. 1998 Nov;4(11):1302–1307. doi: 10.1038/3293. [DOI] [PubMed] [Google Scholar]
  9. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol. 1995 Dec;2(12):1075–1082. doi: 10.1038/nsb1295-1075. [DOI] [PubMed] [Google Scholar]
  10. Malashkevich V. N., Chan D. C., Chutkowski C. T., Kim P. S. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9134–9139. doi: 10.1073/pnas.95.16.9134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tan K., Liu J., Wang J., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12303–12308. doi: 10.1073/pnas.94.23.12303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 1997 May 22;387(6631):426–430. doi: 10.1038/387426a0. [DOI] [PubMed] [Google Scholar]
  13. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Matthews T. J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770–9774. doi: 10.1073/pnas.91.21.9770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wild C., Oas T., McDanal C., Bolognesi D., Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10537–10541. doi: 10.1073/pnas.89.21.10537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wingfield P. T., Stahl S. J., Kaufman J., Zlotnick A., Hyde C. C., Gronenborn A. M., Clore G. M. The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization. Protein Sci. 1997 Aug;6(8):1653–1660. doi: 10.1002/pro.5560060806. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES